Merck buys Cubist Pharmaceuticals in $9.5B deal

Another big pharmaceutical deal was announced on Monday in a year notable for its big pharmaceutical deals. Merck said it was buying Cubist Pharmaceuticals for $102 per share in a deal valued at $9.5 billion.